Evidence map›Paper›PMID 24082084›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Loss of metabotropic glutamate receptor 2 escalates alcohol consumption.

Zhifeng Zhou, Camilla Karlsson, Tiebing Liang, Wei Xiong, Mitsuru Kimura, Jenica D Tapocik, Qiaoping Yuan, Estelle Barbier, Austin Feng, Meghan Flanigan and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. mGlu2 Receptors in the Basal Ganglia: A New Frontier in Addiction Therapy.Frontiers in bioscience (Landmark edition) · 2025
    Review
  5. Review
  6. Article
  7. Pleiotropic Effects ofBiomolecules · 2025
    Review
  8. Synaptic Effects Induced by Alcohol.Current topics in behavioral neurosciences · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Advances in translating mGluPharmacology, biochemistry, and behavior · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.Neuroscience and biobehavioral reviews · 2022
    Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Zhifeng ZhouLaboratories of Neurogenetics and Clinical and Translational Studies and Section on Synaptic Pharmacology, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892.
Camilla Karlsson
Tiebing Liang
Wei Xiong
Mitsuru Kimura
Jenica D Tapocik
Qiaoping Yuan
Estelle Barbier
Austin Feng
Meghan Flanigan
Eric Augier
Mary-Anne Enoch
Colin A Hodgkinson
Pei-Hong Shen
David M Lovinger
Howard J Edenberg
Markus Heilig
David Goldman
National Institute on Alcohol Abuse and Alcoholism · USNational Institutes of Health · USIndiana University – Purdue University Indianapolis · US

Funding

Integrative genetics of behavior with high throughput technologiesZIAAA000301 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GOLDMAN, DAVID · 2009 to 2025
$68.6M
Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Marian Lee Logrip · 2003 to 2026
$45.5M
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of AbuseZIAAA000407 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LOVINGER, DAVID M · 2009 to 2025
$29.6M
Discovery and validation of novel targets for pharmacotherapy of alcoholismZIAAA000487 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LOVINGER, DAVID M · 2009 to 2015
$23.6M
NIAAA NIH HHS P60 AA007611NIAAA NIH HHS P60-AA007611
6 · The paper itself

Abstract

Identification of genes influencing complex traits is hampered by genetic heterogeneity, the modest effect size of many alleles, and the likely involvement of rare and uncommon alleles. Etiologic complexity can be simplified in model organisms. By genomic sequencing, linkage analysis, and functional validation, we identified that genetic variation of Grm2, which encodes metabotropic glutamate receptor 2 (mGluR2), alters alcohol preference in animal models. Selectively bred alcohol-preferring (P) rats are homozygous for a Grm2 stop codon (Grm2 *407) that leads to largely uncompensated loss of mGluR2. mGluR2 receptor expression was absent, synaptic glutamate transmission was impaired, and expression of genes involved in synaptic function was altered. Grm2 *407 was linked to increased alcohol consumption and preference in F2 rats generated by intercrossing inbred P and nonpreferring rats. Pharmacologic blockade of mGluR2 escalated alcohol self-administration in Wistar rats, the parental strain of P and nonpreferring rats. The causal role of mGluR2 in altered alcohol preference was further supported by elevated alcohol consumption in Grm2 (-/-) mice. Together, these data point to mGluR2 as an origin of alcohol preference and a potential therapeutic target.

Indexed as

Codon, TerminatorReceptors, Metabotropic GlutamateAlcohol DrinkingAnimalsCrosses, GeneticExcitatory Amino Acid AntagonistsGene Expression RegulationGlutamic AcidMiceMice, KnockoutRatsRats, WistarSynapsesSynaptic TransmissionCodon, TerminatorExcitatory Amino Acid AntagonistsGlutamic Acidmetabotropic glutamate receptor 2Receptors, Metabotropic Glutamategene identificationselectively bred lines

Identifiers

PMID24082084
PMCPMC3800985
OpenAlexW2041253023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.